Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma. - Wikidata - awgldk - TriplyDB

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

http://www.wikidata.org/entity/Q37001025

about

GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.Identifying volatile metabolite signatures for the diagnosis of bacterial respiratory tract infection using electronic nose technology: A pilot study.

P2860

Q38853863-333DA591-2004-4D9F-969C-12E0F91BDDF2 Q47134751-9E6EDB3B-83DE-4519-9A53-26E1E7D49207

P2860

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

http://www.wikidata.org/entity/Q37001025

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@en

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@nl

type

label

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@en

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@nl

prefLabel

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@en

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@nl

P1433

Q37001025-8C0D3875-E760-4893-B0F8-AC21F835891B

P1476

Q37001025-D44D302B-6802-4CB6-A1D5-181BF18BEDF2

P2093

Q37001025-1189B032-3D9C-49BF-A3D1-586CDADD9AB3

Q37001025-225428B3-0133-4B90-9EBE-CD623E0329AA

Q37001025-58B7948E-285E-4D7D-AB12-FD52A59AC409

Q37001025-607AD7A9-E3A6-462E-81FE-78BFD70C65C9

Q37001025-6C04DDD4-0A9A-4F79-9AF7-220556086AF9

Q37001025-C8DE40BA-0806-4676-A2DD-E80551EB64E0

Q37001025-D532E9B3-761F-4812-912A-A42C3DA681C5

Q37001025-E35B1F6E-BD48-4193-8A58-3DADDD1FDC5D

Q37001025-FC67FDC0-0583-41B6-9B2E-1E21CF93ECD4

Q37001025-FFAECD80-4790-4D18-8276-A93F2761A93A

P2860

Q37001025-07F72B65-8E94-4598-BE70-D5EF99A30EDE

Q37001025-0BD740BA-5A9C-4A98-89B3-95CAD26407F4

Q37001025-0EA69228-1AFB-40DF-8FBF-C7E2D2CDB512

Q37001025-19DB078B-4DA4-411C-9516-7978CE768E0C

Q37001025-2ACBD831-4276-463C-B312-3B09B104CC03

Q37001025-51815DED-4023-486F-AE0E-A5B809FCD452

Q37001025-5FE524AD-92F6-4A4D-A369-4E0F0BBEC23E

Q37001025-632A7DC3-F44F-4F86-B249-6D5CD5C4FB13

Q37001025-69A9B0D9-AFD6-4E80-A677-F80DCCD672BB

Q37001025-70CEDD7D-29DF-48A0-B06A-C09342AD7283

P304

Q37001025-2FCF8607-DAAC-4799-9501-A613556A488B

P31

Q37001025-8595119A-1285-4C2E-843F-C18551D1FBE3

P356

Q37001025-2D600A1D-3BAF-4A30-85E2-EDDC10542A81

P433

Q37001025-36A68E52-DBD6-4ECC-9243-57958FB3D70A

P478

Q37001025-F9568115-E285-4D80-898D-C17EA59E643A

P577

Q37001025-BA15A1C6-8779-474E-8F9E-6408B724C33E

P698

Q37001025-26EFF522-FB20-4EE1-861D-DD3C37F510E6

P921

Q37001025-CAEEAEFA-9CDF-43E9-A285-F3D9D3E9AC21

Q37001025-D8EFF93D-643E-4FD5-87EF-A7F911A471F1

Q37001025-E5908F23-6C17-42AC-BDBB-FBE0F05E689B

P932

Q37001025-84D3DAC1-BA92-44FD-8FC5-1955928B697F

P356

P1433

Biomedical Reports

P1476

Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

@en

P2093

Changsong Wang

http://www.w3.org/2001/XMLSchema#string

Dongchun Wang

http://www.w3.org/2001/XMLSchema#string

Enyou Li

http://www.w3.org/2001/XMLSchema#string

Lei Guo

http://www.w3.org/2001/XMLSchema#string

Mingjuan Li

http://www.w3.org/2001/XMLSchema#string

Wei Hou

http://www.w3.org/2001/XMLSchema#string

Xin Pi

http://www.w3.org/2001/XMLSchema#string

Yue Feng

http://www.w3.org/2001/XMLSchema#string

Yue Wang

http://www.w3.org/2001/XMLSchema#string

Ziwei Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Urine metabolomics for kidney cancer detection and biomarker discovery

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia

Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis.

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.

Temporal profiling of human urine VOCs and its potential role under the ruins of collapsed buildings.

Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.

Urinary nucleosides as biological markers for patients with colorectal cancer.

P304

68-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2016.686

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27347408

http://www.w3.org/2001/XMLSchema#string

P921

volatile organic compound

P932

4906617

http://www.w3.org/2001/XMLSchema#string